Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

3-Bromo-D-Phenylalanine

    • Product Name 3-Bromo-D-Phenylalanine
    • Alias m-Br-D-Phe
    • Einecs 257-581-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    632371

    Product Name 3-Bromo-D-Phenylalanine
    Chemical Formula C9H10BrNO2
    Molecular Weight 244.09 g/mol
    Cas Number 120337-71-5
    Appearance White to off-white solid
    Optical Activity D-isomer
    Purity Typically ≥98%
    Solubility Soluble in water and various organic solvents
    Synonyms D-3-Bromophenylalanine

    As an accredited 3-Bromo-D-Phenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 3-Bromo-D-Phenylalanine

    Applications of 3-Bromo-D-Phenylalanine in Industrial Manufacturing

    3-Bromo-D-Phenylalanine stands as a key chiral building block serving advanced sectors where strict quality, enantiopurity, and regulatory adherence define product value. We supply this specialized amino acid to downstream industries who employ it as a core intermediate, ensuring traceable lot control, tight assay specifications, and application-specific technical support for consistent integration into high-value production flows.

    1. Peptide Drug Synthesis

    Pharmaceutical peptide manufacturers rely on 3-Bromo-D-Phenylalanine for assembling bioactive compounds with enantioselective pharmacological profiles. It is introduced during solid-phase peptide synthesis (SPPS) as a protected amino acid derivative, facilitating site-specific modification of side chains crucial for receptor selectivity and metabolic stability in clinical-stage molecules, especially anti-cancer and metabolic disorder candidates.

    Industry compliance standards

    • ICH Q7 GMP Guidelines
    • USP & EP Chiral Amino Acid Monographs
    • FDA 21 CFR 210/211

    Typical usage ratio

    • 0.5–6% molar basis relative to peptide chain—varies with peptide length and target sequence modification sites

    Downstream process integration

    • Direct coupling as an Fmoc or Boc-protected amino acid in programmable peptide assembly cycles
    • Deprotection and purification via preparative HPLC prior to formulation

    Final product types

    • Active pharmaceutical ingredient (API) grade peptide therapeutics
    • Clinical trial materials (parenteral and oral peptides)
    • Research-only peptide standards

    2. Chiral Intermediate for Small Molecule APIs

    Several small molecule drug substance producers deploy this raw material as a stereospecific synthon in multi-step chemical pathways requiring halogenated phenylalanine motifs. Its bromo-substituent allows for downstream Suzuki or Heck cross-coupling, expanding synthetic possibilities in medicinal chemistry programs targeting central nervous system and oncology therapeutics where off-target profiles are reduced by configuration control.

    Industry compliance standards

    • ICH Q11 Drug Substance Development
    • FDA Guidance for Industry: Q8(R2)
    • Pharmaceutical Inspection Co-operation Scheme (PIC/S) GMP standards

    Typical usage ratio

    • 0.3–2% w/w of total input in convergent synthesis blocks—adjusted for step economy and target batch scale

    Downstream process integration

    • Introduced at protected amino acid-bromo functionalization stage
    • Participates in substitution or metal-catalyzed cross-coupling before deprotection and crystallization

    Final product types

    • Halogenated chiral intermediates for API registration
    • Branched-chain analogues in CNS drug scaffolds
    • Reference materials for method validation

    3. Diagnostic Peptide Markers

    The in vitro diagnostics (IVD) sector incorporates 3-Bromo-D-Phenylalanine into synthetic peptides for labelled markers and immobilized ligands designed for immunoassays, biosensor development, and mass spectrometry standards. The heavy atom in the side chain ensures clear differentiation in analytic platforms, supporting repeatable calibration and traceability for clinical sample testing reagents.

    Industry compliance standards

    • ISO 13485:2016 – Medical Device QMS
    • EN ISO 17511:2020 – Reference Measurement Systems
    • FDA 21 CFR Part 820 – Quality System Regulation

    Typical usage ratio

    • 0.2–1.2% by mass in peptide marker stock preparations; fine-tuned according to detection sensitivity

    Downstream process integration

    • Incorporation during solution or solid-phase synthesis of peptide markers
    • Covalent attachment or isotopic labelling prior to panel formulation

    Final product types

    • Mass spectrometry calibration mixtures
    • In vitro immunoassay reagents
    • Peptide reference standards for clinical diagnostics

    4. Fine Chemical Building Block for Agrochemical Research

    Contract research organizations and agrochemical innovators use this compound as a functionalized chiral amine in the construction of small-scale analogues for regulatory studies on crop protection candidates. Its defined stereochemistry enables biological activity profiling and SAR studies before scale-up, and its bromo handle provides rapid diversification via palladium-catalyzed arylation.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • ISO 9001:2015 (as applied to chemical research materials)
    • European Chemicals Agency REACH for intermediate use

    Typical usage ratio

    • 0.1–2.5% by mol in agrochemical lead candidate synthesis reactions, varying with synthetic step and target molecule load

    Downstream process integration

    • Setup as an aryl or amine core in initial lead generation reactions
    • Undergoes cross-coupling, amidation, or cyclization en route to structure-activity screening compounds

    Final product types

    • Preclinical crop protection analogues
    • SAR library members for herbicide/pesticide development
    • GLP standard reference compounds

    5. Enzyme Substrate Design for Biocatalysis R&D

    Enzyme engineering and applied biocatalysis labs select 3-Bromo-D-Phenylalanine when building substrate analogues for specificity and kinetics evaluation. Its unique structure allows researchers to probe enzyme binding pockets, map stereoselectivity, and develop new catalysts for halogenated substrate conversion. This supports custom enzyme screening batches in pharma and green chemistry initiatives.

    Industry compliance standards

    • OECD GLP for research chemicals
    • ISO/IEC 17025:2017 for testing laboratory processes
    • Institutional chemical safety and risk protocols

    Typical usage ratio

    • 0.05–1% of total substrate pool during enzyme assay development—adapted to substrate turnover and detection requirements

    Downstream process integration

    • Preparation of labelled substrate batches for enzyme activity testing
    • Inclusion in combinatorial or single-substrate kinetic assays

    Final product types

    • Biocatalysis test kits
    • Novel enzyme variants optimized for synthetic chemistry
    • Research-only substrate libraries
    Free Quote

    Competitive 3-Bromo-D-Phenylalanine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Discovering the Unique Value of 3-Bromo-D-Phenylalanine

    Every so often, the world of chemical synthesis comes across a compound that manages to change a few rules at the bench. 3-Bromo-D-Phenylalanine isn’t a blockbuster in the way you might expect from a catchy trade name product or a pharmaceutical giant’s latest patent, but for anyone doing targeted synthesis, peptide research, or even just trying to customize building blocks for a unique branch on a complex molecule, this molecule stands out for reasons that become clear with a bit of hands-on experience.

    Understanding 3-Bromo-D-Phenylalanine: Structure and Model

    3-Bromo-D-Phenylalanine shows up as a derivative of the common α-amino acid, phenylalanine, but with a bromine atom sitting on the third carbon of the aromatic ring, all in the D-configuration. Chemists know that a single swapped atom or even a different chiral form can open up new pathways—sometimes literally allowing a different enzyme recognition or a divergent chemical reactivity. The way bromine, a heavy atom, alters the physicochemical profile of the parent amino acid feels immediately significant in any application that relies on high selectivity.

    From a practical perspective, anybody who’s ever ordered fine chemical reagents knows that small changes in structure often result in major shifts in performance. Bromine’s presence brings in extra steric hindrance and distinctive electronic properties. The D-stereoisomer, in turn, resists most biological degradations that target natural L-amino acids. This isn’t a detail stuck at the end of a spec sheet; it’s the difference between a probe that vanishes overnight in a cell culture dish and one that hangs around long enough to actually convey a signal or inhibit a process.

    Applications and Real-World Usage

    The research community turns to 3-Bromo-D-Phenylalanine for a few predictable but critical reasons. In peptide synthesis, anyone aiming to create non-natural sequences—especially those designed to resist enzymatic breakdown—can make use of the D-form. Substituting a bromine atom brings with it the option for further downstream modifications. In actual lab settings, the bromine often acts as a handle, opening up the chance for Suzuki couplings or other types of cross-coupling chemistry. This effectively hands researchers a toolkit: Need to tack on another aromatic group? The bromine makes it easier. Seeking to introduce further diversity? The options multiply.

    On the bench, the day changes quite a bit with access to tailored building blocks. Peptidomimetics, enzyme inhibitors, and fluorescent probes all get a boost in complexity or selectivity with the strategic use of halogenated amino acids. My own experience in peptide modification taught me the value of even small changes. I remember one series of experiments where simply going from unsubstituted D-phenylalanine to its meta-brominated cousin cut down the number of unintended side products in a solid-phase synthesis run. That single substitution unclogged a week’s worth of stalled work—a reminder that the right tool, even if it looks like a small tweak, can reshape the whole process.

    Researchers concerned with probing protein–protein interactions, or understanding the delicate dance of post-translational modifications, often reach for modified amino acids like 3-Bromo-D-Phenylalanine. The compound doesn’t just blend quietly into the background; it carries a chemical baton that can be passed further to the next step in a synthesis sequence. Peptides made with this building block might resist ordinary proteases, hang around longer in tissue, or bind differently to cellular targets, exactly because of that single bromine sitting where an ordinary hydrogen used to be.

    Specifications That Matter Where It Counts

    The quality of a synthetic amino acid hinges on purity, stereoisomeric fidelity, and consistent performance. Analytical chemists can verify enantiomeric excess by chiral HPLC, making sure the D-form dominates the sample. Purity, typically measured by UV or MS analysis, shows whether the batch comes free of side products or degradation fragments. These are not afterthoughts: even a sliver of L-form contamination can throw off biological results, especially in experiments where small peptides are meant to escape enzymatic digestion.

    Another aspect lies in solubility and handling. Anyone dealing with brominated organics knows that sometimes, halogenation nudges a once-easy compound toward lower solubility in polar solvents. In the case of 3-Bromo-D-Phenylalanine, careful crystallization and drying help, and experience tells me that an extra few minutes stirring pays off when it comes time to add to a peptide synthesis resin or a solution-phase reaction. Flow rates on the synthesizer stay predictable, and batch-to-batch consistency leads to fewer headaches for both technicians and principal investigators.

    Comparison with Other Modified Amino Acids

    A seasoned researcher might pause and ask, “Why not just use other halogenated forms, or stick with L-phenylalanine derivatives?” In the spectrum of halogenated phenylalanines, the position and choice of halogen matters a great deal. 4-bromo variants, for instance, bring different reactivity and steric effects, affecting downstream chemistry in subtle but significant ways. Using chlorine or fluorine instead of bromine gives compounds that react, elute, or even smell differently in the lab. Bromine’s unique combination of size and reactivity opens doors in cross-coupling reactions, especially for introducing large substituents or custom labels. Not every lab needs this, but the difference becomes apparent as soon as you try extending a peptide chain or preparing a labeled probe.

    Switching from L- to D-forms does more than just slow down breakdown by common proteases; it completely reroutes biological interactions. Peptidomimetic drug development often counts on exactly this property, letting drug candidates evade the body’s usual cleanup crew while still binding to their intended targets. It’s a subtle but powerful shift that changes not just the half-life of the compound, but also its potential to reach and stick to intended biomolecules.

    Impact on Research and Industry

    Plenty of academic and industrial labs rely on modified amino acids to create new biomaterials, molecular probes, and therapeutic candidates. Access to a reliable supply of 3-Bromo-D-Phenylalanine changes what’s possible at the planning stage of a project. Ideas that might have been relegated to the “nice, but not now” pile come down to feasibility, not wishful thinking. In my own projects, collaborative brainstorming often drifted toward next-generation peptides or side-chain modifications. The sudden availability of a uniquely brominated, D-configured phenylalanine often translated those ideas into action within a single grant cycle.

    Large pharmaceutical companies and startups alike keep a close eye on the evolution of amino acid building blocks. Modified peptides, sitting on the frontier of oral bioavailability and drug targeting, owe some of their progress to readily available reagents like 3-Bromo-D-Phenylalanine. Even outside the life sciences, chemists in materials science find value, as this building block influences the assembly and function of custom polymers and surface coatings. There’s a ripple effect that extends far beyond the walls of a single discipline.

    Why Structure and Purity Go Hand in Hand

    Anyone who’s struggled through a tricky synthesis knows the frustration of unexplained signal loss or low yield. Part of the headache disappears with high-purity reagents. There’s less troubleshooting. You spend more time doing real science and less time debugging process hiccups caused by contaminants or inconsistent stereochemistry. The confidence to plan complex sequences comes from knowing the building blocks behave as expected. Having the exact 3-Bromo-D-Phenylalanine in hand isn’t just about hitting a spec; it’s about unleashing creativity without worrying about off-target reactions or hidden impurities.

    Stereochemical integrity matters even more when you work with biologically active molecules. Minute traces of the wrong enantiomer can lead to confounding results, introducing noise in bioassay data or triggering unexpected responses in animal models. Reliable suppliers use validated routes, careful controls, and transparent documentation. Chemists, for their part, often cross-check with NMR, chiral HPLC, and MS—sometimes all three, just to be sure. Trust in the source translates directly to trust in experimental outcomes.

    Possible Solutions to Challenges in Working with Specialty Amino Acids

    While specialty compounds like 3-Bromo-D-Phenylalanine bring new capabilities, they can also pose real-world handling and sourcing challenges. One common issue revolves around stability and shelf life. The bromine atom, while invaluable for subsequent reactions, can sometimes make the compound more susceptible to light or air than its non-halogenated relatives. Shipping with proper protection, storing away from direct sunlight, and using protective atmospheres during long storage cuts down on waste and surprises. In my own workflows, proper documentation and batch labeling lets everyone see at a glance which samples remain in optimum condition.

    Another stumbling block sometimes comes with scale. Small lab orders might seem easy, but scaling up production for industry or large-scale research means new variables. Solvent systems, reaction optimization, and even purification techniques all need revisiting when grams turn into kilograms. Open lines of communication between suppliers and end users can make a difference here; a spec sheet won’t always surface small-scale quirks that turn into big headaches at scale-up.

    Scientists benefit from transparent data sharing—not just published protocols, but honest stories about what worked and what didn’t. I once exchanged notes with a colleague who spent days troubleshooting a coupling reaction, only to solve the problem with a minor solvent adjustment. That conversation saved me at least a week on a parallel project. Building communities or open-access repositories for troubleshooting specialty amino acid transformations contributes to more robust and reproducible science.

    Ethical Considerations and Responsible Sourcing

    Any time a chemical becomes important for research or production, supply chain integrity moves to the front of the line. Ethical sourcing doesn’t only relate to the big-ticket items—rare metals or controlled substances—but also to more routine reagents. Verifying that reagents arrive free from regulatory red flags or environmental shortcuts helps everyone sleep easier at night. Suppliers who invest in environmentally friendly production, use less hazardous reagents, and provide full traceability add value far beyond the chemical’s data sheet. The customer’s confidence grows not just in the molecule’s immediate quality, but in the research enterprise as a whole.

    The broader implications touch on social trust. Transparency in chemical manufacturing, routine quality checks, and authentic documentation protect not just individual labs, but also the reputation of industries and scientific institutions. This atmosphere of shared responsibility supports robust innovation in peptide science, drug development, and molecular engineering.

    Health and Safety in the Lab

    A compound’s technical merit only gets you so far; safe and informed handling matters equally. Brominated organics have a reputation for demanding careful treatment and responsible waste management. Personal experience underlines the importance of clear labeling, chronicling not just concentration but also any special precautions. Fume hoods, gloves, and proper waste streams aren’t just bureaucratic hurdles—they’re non-negotiable steps for anyone wanting to avoid accidents or long-term health issues.

    Training also factors in, particularly for students and early-career scientists. Instead of throwing information sheets their way, real mentoring means walking through the actual process—how to dissolve, weigh, and dispose of specialty amino acids. This builds a culture of competence that makes accidents less likely and paves the way for more advanced projects down the road.

    Long-Term Impact on Science and Product Development

    Research stands on the back of reliable building blocks. Halogenated amino acids, including 3-Bromo-D-Phenylalanine, expand the palette for scientists painting the future of proteins, drugs, and new materials. Access to these isn’t just a convenience—it’s a key that unlocks more ambitious projects. The next step in imaging, targeted drug delivery, or even artificial enzyme design might begin with the right substitution at exactly the right spot in a molecule.

    In practice, this means that labs pursuing protein engineering don’t have to settle for off-the-shelf amino acids. The option to choose precisely tailored derivatives enables experiments that probe the subtle influences of electronic and steric effects, even helping to trace metabolic fates in live organisms. This isn’t just a theoretical advantage. One group’s work on engineered ligands for protein receptors drew directly on the availability of bromo-derivatives to generate tailored cross-linkers—knitting peptides into stable, functional networks that ordinary residues couldn’t achieve.

    Addressing Future Needs in Research and Innovation

    With science advancing on so many fronts at once, the expectations for specialty reagents will only grow. Holding the line on quality, documentation, and availability takes ongoing investment from suppliers and continued scrutiny from scientists. Tighter collaboration, rapid feedback loops, and shared best practices form the foundation for progress.

    My time in the lab taught me that innovation doesn’t always come from the latest gadget or headline—sometimes it’s having exactly the right molecule, available at exactly the moment when inspiration hits. 3-Bromo-D-Phenylalanine isn’t a cure-all, but for the right project, in the right hands, it moves the dial further than most realize.

    Keeping Quality Front and Center

    In the end, the value of a specialty amino acid boils down to more than technical specifications. It rests on the proven track record it brings—batch after batch, synthesis after synthesis. Having access to well-characterized, high-purity 3-Bromo-D-Phenylalanine removes doubts and opens paths toward elegant, clean chemistry. The landscape of drug discovery, peptide engineering, or materials science is vast, and progress depends on turning today’s dreams into tomorrow’s realities. The right chemical building block won’t solve every challenge, but it often marks the first real step in the next chapter of discovery.